The institution grant opens a trial phase expected to conclude with a final written decision within about 12 months. Monitor for the final decision and any related district-court or ITC litigation that the decision may reference in subsequent papers.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $641.39entry
- T+1 · 6d ago −1.97%α −3.29% · $628.77
- T+4 · todayOpen
- T+5 · in 9h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outExecutive Summary
The PTAB instituted inter partes review (IPR2026-00376) of Solos Technology Limited's patent covering eyewear systems, apparatus, and methods for providing assistance to a user. Meta Platforms, Inc., as a co-petitioner, cleared the threshold for trial on the challenged claims; no claims have been cancelled yet.
PTAB Trial Details
Key Facts
- PTAB instituted IPR2026-00376 on November 10, 2026
- Patent: U.S. 12216339, 'EYEWEAR SYSTEMS, APPARATUS, AND METHODS FOR PROVIDING ASSISTANCE TO A USER'
- Patent owner: Solos Technology Limited
- Petitioners: Luxottica of America Inc.; Meta Platforms, Inc.
- Institution granted means the Board found a reasonable likelihood Meta would prevail on at least one challenged claim
- This is an interlocutory decision; no claims have been cancelled
Financial Impact
No financial figures stated in the decision; the patent covers eyewear systems, which may relate to Meta's smart glasses products, but no revenue or damages are quantified
Risk Factors
- Interlocutory ruling only, no claims have been invalidated; the patent remains in force
- If the final written decision cancels claims covering Meta's smart glasses products, it could reduce infringement risk; if claims survive, Meta may face continued exposure
- No related litigation or product-specific revenue exposure is stated in the decision
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 PTAB decision.
| Document | Accession Number |
|---|---|
| PTAB-TRIAL Data (Synthetic) | ptab-IPR2026-00376-ins-META |
Track record
175 reports on META
19 of 35 bullish or bearish reports moved the stock their way by T+1. Best: +31.62% at T+20 after the Aug 26, 2026 report. 25 of 35 went positive at some point.
Filters
- Nov 13, 20264d ago Court Ruling Bullish 5/10 No price data
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $641.69 to $626.41 Now $626.41 −2.38% ▼ −2.38% −0.47% vs SPY
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $641.69 to $626.41 Now $626.41 −2.38% ▼ −2.38% −0.47% vs SPY
- Nov 12, 20265d ago Court Ruling Neutral 2/10 Entry $641.69 to $626.41 Now $626.41 −2.38% ▼ −2.38% −0.47% vs SPY
- Nov 10, 20267d ago PTAB Trial Neutral 3/10 Viewing Entry $641.39 to $628.77 Now $626.41 −2.34% ▼ −1.97% −3.29% vs SPY
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $641.39 to $628.77 Now $626.41 −2.34% ▼ −1.97% −3.29% vs SPY
- Nov 6, 202610d ago 424B5 Neutral 3/10 Entry $610.15 to $641.37 Now $626.41 +2.66% ▲ +5.12% +2.75% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $610.15 to $641.37 Now $626.41 +2.66% ▲ +5.12% +2.75% vs SPY
- Nov 4, 202612d ago 424B5 Neutral 3/10 Entry $605.08 to $610.15 Now $626.41 +3.53% ▲ +0.84% +0.53% vs SPY
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $605.08 to $610.15 Now $626.41 +3.53% ▲ +0.84% +0.53% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time PTAB Decision Intelligence
Market-moving PTAB patent decisions analyzed within minutes. Trial institutions, denials, final written decisions, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers